Literature DB >> 11506513

Methicillin resistant Staphylococcus aureus in patients undergoing major amputation.

S A Grimble1, T R Magee, R B Galland.   

Abstract

OBJECTIVES: To examine the impact of MRSA infection on patients undergoing major amputation.
SETTING: District General Hospital.
METHODS: Patients having had major amputation and positive MRSA cultures January 1995-December 1999 were included. Outcome was compared with a randomly chosen group of patients having major amputation but no positive MRSA culture from the same time period.
RESULTS: overall 21% of patients undergoing amputation were MRSA positive. Some 28 patients (30 amputations) with MRSA positive cultures were compared with 44 patients (54 amputations) who did not have positive cultures for MRSA. MRSA was isolated from the wound in 17 of 30 amputations. More patients in the control group had a below knee amputation (38 of 54 compared with 12 of 30, p<0.02). Mortality in MRSA positive patients was higher than controls, (12 of 28, 43%, versus 4 of 44, 9%, p<0.01). Primary healing was achieved in only 4 of 17 (24%) amputations where MRSA was isolated from the wound. This compared with 31 of 54 (57%) controls (p<0.05). Delayed healing due to chronic infection was also more likely in MRSA positive patients (p<0.01).
CONCLUSION: In view of the high morbidity and mortality in patients with MRSA positive isolates specific antibiotic prophylaxis against MRSA should be considered in patients undergoing major amputation.

Entities:  

Mesh:

Year:  2001        PMID: 11506513     DOI: 10.1053/ejvs.2001.1436

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms.

Authors:  Athanasios N Athanasopoulos; Matina Economopoulou; Valeria V Orlova; Astrid Sobke; Darius Schneider; Holger Weber; Hellmut G Augustin; Sabine A Eming; Uwe Schubert; Thomas Linn; Peter P Nawroth; Muzaffar Hussain; Hans-Peter Hammes; Mathias Herrmann; Klaus T Preissner; Triantafyllos Chavakis
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

2.  Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?

Authors:  Bruce Y Lee; Becky Y Tsui; Rachel R Bailey; Kenneth J Smith; Robert R Muder; G Jonathan Lewis; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

3.  Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.

Authors:  Sanjay Chhibber; Tarsem Kaur
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

4.  Non-aqueous glycerol monolaurate gel exhibits antibacterial and anti-biofilm activity against Gram-positive and Gram-negative pathogens.

Authors:  Elizabeth A Mueller; Patrick M Schlievert
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

5.  Salmon cartilage proteoglycan promotes the healing process of Staphylococcus aureus-infected wound.

Authors:  Shouhei Hirose; Kouji Narita; Krisana Asano; Akio Nakane
Journal:  Heliyon       Date:  2018-03-27

6.  Surgical Antimicrobial Prophylaxis in Patients of Neonatal and Pediatric Age Undergoing Orthopedic and Hand Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Francesca Opri; Sonia Bianchini; Laura Nicoletti; Sara Monaco; Roberta Opri; Marilia Di Pietro; Elena Carrara; Erika Rigotti; Cinzia Auriti; Caterina Caminiti; Daniele Donà; Laura Lancella; Andrea Lo Vecchio; Simone Pizzi; Nicola Principi; Alessandro Simonini; Simonetta Tesoro; Eisabetta Venturini; Alberto Villani; Annamaria Staiano; Leonardo Marchesini Reggiani; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.